CELARES
The outstanding growth of the pharmaceutical biotechnology industry means new challenges for classical pharmaceutical companies. Especially big companies often lack the capability, flexibility, and required speed of operation to develop the necessary technological know-how for the formulation of biopharmaceuticals within the company.
CELARES
Social Links:
Industry:
Biotechnology Pharmaceutical
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.celares.com
Status:
Active
Contact:
+ 49 (0) 30 94 89 23 50
Email Addresses:
[email protected]
Similar Organizations
BIOMM
BIOMM engages in the biotechnology industry.
geneOmbio
geneOmbio is a pharmaceutical and biotechnology company.
Project Support
Project Support is a consulting services to the pharmaceutical and biotechnology industry.
Spero Oncology
Spero Oncology is a pharmaceutical, biotechnology and medical device firm.
Official Site Inspections
http://www.celares.com
- Host name: 91-203-75-115.dc7.ccsleeds.co.uk
- IP address: 91.203.75.115
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Celares"
Celares - Crunchbase Company Profile & Funding
Celares is a pharmaceutical biotechnology industry means new challenges for classical pharmaceutical companies. Especially big companies often lack the capability, flexibility, and …See details»
Cellares - The First Integrated Development and Manufacturing ...
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The …See details»
Celares GmbH - Life-Sciences-Europe.com
Celares GmbH is focused on development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. Established in 2003 and based in Berlin, Germany, celares …See details»
celares Company Profile 2024: Valuation, Investors, …
Celares General Information Description. Developer of conjugate vaccines and bioconjugate drugs intended to serve diagnostic and pharmaceutical companies. The company GMP production of bioconjugates and functionalized polymers …See details»
celares - Ownership and Business Overview - Mergr
Jul 11, 2023 celares is a provider in the development and manufacture of conjugate vaccines and bioconjugate drugs, activated PEGs, and polymer-based drug delivery excipients. celares …See details»
Celares - Overview, News & Similar companies | ZoomInfo.com
Who is Celares. Celares GmbH, Berlin, Germany, a privately-owned company, is a recognized leader in the field of pegylation and chemical modification of biopharmac euticals. The …See details»
Celares - pharmaceutical-tech.com
Celares GmbH is a privately owned company, established in 2003, and a recognized leader in the field of bioconjugation/half-life extension by chemical modification and the synthesis of …See details»
Company - Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The …See details»
Celares - Company Profile - Tracxn
Nov 27, 2024 celares specializes in PEGylation, a special form of drug delivery for biopharmaceuticals, especially for peptide and protein drugs, respectively. The company holds …See details»
Cellares - LinkedIn
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.See details»
Cellares Raises $255M Series C to Launch First Integrated …
SOUTH SAN FRANCISCO, August 23, 2023 – Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy …See details»
Cellares Company Profile 2024: Valuation, Funding & Investors
Operator of an Integrated Development and Manufacturing Organization committed to accelerating patients' access to life-Other Devices and Supplies. South San Francisco, CA. …See details»
Cellares Raises $255M Series C to Launch First Integrated …
Aug 23, 2023 Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st …See details»
Cellares - Crunchbase Company Profile & Funding
Cellares may be growing as it has recently achieved a significant regulatory milestone by gaining cGMP for its Cell Shuttle, which is a critical step in advancing towards clinical applications.See details»
Cellares - Overview, News & Similar companies | ZoomInfo.com
Jul 8, 2024 Cellares Appoints Justin McAnear as CFO and Jonathan Butler as General Counsel SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, a leader in cell therapy …See details»
Startup Cellares adds $255M as investors pour cash into cell …
Aug 24, 2023 Dive Brief: Cellares, a biotechnology startup that bills itself as the first “integrated” development and manufacturing organization dedicated to cell therapy, raised $255 million in …See details»
Cellares - Work in biotech
The Shuttle is a closed system enabling a 70% cost reduction and a 3-fold reduction in failure rates. Customers can design and monitor their cell therapy production with the Cellares …See details»
Cellares Announces Agreement with Kite to Evaluate Its Cell …
Jun 27, 2024 Cellares is the first Integrated Development and Manufacturing Organization (IDMO) that takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st …See details»
BMS backs $255m round for contract cell maker Cellares
2 days ago Cellares has just closed a major $255 million third-round financing that will be used to complete a highly automated facility in New Jersey for the production of cell therapies.See details»
Fully Automated, Scalable, Cell Therapy Manufacturing - Cellares
Purpose-built Technology Powers the First Integrated Development & Manufacturing Organization (IDMO) Reagent Vault System (RVS) Capacity for up to 200 automation-friendly reagent …See details»